1997 Loophole - US Pharma Marketing

FDA Expands Crackdown on Deceptive DTC Ads with New Rulemaking: Closing the 1997 Loophole and Redefining Pharma Marketing

Case Studies & Trends

FDA Expands Crackdown on Deceptive DTC Ads with New Rulemaking: Closing the 1997 Loophole and Redefining Pharma Marketing

The pharmaceutical industry has long relied on glossy direct-to-consumer (DTC) ads to shape patient behavior. From … FDA Expands Crackdown on Deceptive DTC Ads with New Rulemaking: Closing the 1997 Loophole and Redefining Pharma MarketingRead more

by Gurinder Khera•September 22, 2025September 22, 2025•0